doi:10.1016/j.drudis.2015.10.016 110
Exclusive interview: Jens Juul Holst His is not a household name, but the drugs developed thanks to Danish scientist Jens Juul Holsts research certainly are
A licensed provider will assess your health history and determine whether semaglutide or tirzepatide is appropriate for you
Implications for pharma marketers: The expansion into newly approved health conditions points to a growing role for GLP-1 drugs across chronic diseases
"Health care touches people in the most real and personal moments of their lives."Katya Andresen, chief digital and analytics officer, The Cigna Group Our job is to make those moments simpler, clearer, more connected, and more human," Andresen said
Nicht empfohlen fr Personen, die an einer Krankheit leiden und oder Medikamente einnehmen, sowie fr Kinder und schwangere oder stillende Frauen